Skip to main content
Top
Published in: Journal of General Internal Medicine 8/2020

01-08-2020 | Naloxone | Letter to the Editor

Prescribers and Naloxone Pharmacy Claims

Published in: Journal of General Internal Medicine | Issue 8/2020

Login to get access

Excerpt

We appreciate the response from Truong, Patil, and Rich to our study regarding retail pharmacy naloxone prescriptions1 and thank them for highlighting the importance of patient and caregiver education for individuals receiving naloxone. While naloxone is generally considered a safe medication, like almost all medications, there are risks of unintended adverse consequences if not used as intended. It is essential that prescribers educate patients and caregivers regarding the circumstances when naloxone should be administered, and the procedures for administering it, when writing a naloxone prescription. In addition, since nearly all states have laws or policies that allow individuals to obtain naloxone from a pharmacist without a prescription from a physician, pharmacists also play a critical role in counseling patients and caregivers regarding the circumstances when naloxone should be administered and proper procedures for administration.2
Literature
1.
go back to reference Smart R, Geiger CK, Jones CM, Stein BD. An Observational Study of Retail Pharmacy Naloxone Prescriptions: Differences Across Provider Specialties and Patient Populations. J Gen Intern Med. 2019. Smart R, Geiger CK, Jones CM, Stein BD. An Observational Study of Retail Pharmacy Naloxone Prescriptions: Differences Across Provider Specialties and Patient Populations. J Gen Intern Med. 2019.
2.
go back to reference Thakur T, Frey M, Chewning B. Pharmacist roles, training, and perceived barriers in naloxone dispensing: A systematic review. J Am Pharm Assoc (2003). 2020;60(1):178–94. Thakur T, Frey M, Chewning B. Pharmacist roles, training, and perceived barriers in naloxone dispensing: A systematic review. J Am Pharm Assoc (2003). 2020;60(1):178–94.
3.
go back to reference Zaller ND, Yokell MA, Green TC, Gaggin J, Case P. The feasibility of pharmacy-based naloxone distribution interventions: a qualitative study with injection drug users and pharmacy staff in Rhode Island. Subst Use Misuse. 2013;48(8):590–9.CrossRef Zaller ND, Yokell MA, Green TC, Gaggin J, Case P. The feasibility of pharmacy-based naloxone distribution interventions: a qualitative study with injection drug users and pharmacy staff in Rhode Island. Subst Use Misuse. 2013;48(8):590–9.CrossRef
Metadata
Title
Prescribers and Naloxone Pharmacy Claims
Publication date
01-08-2020
Published in
Journal of General Internal Medicine / Issue 8/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-020-05791-5

Other articles of this Issue 8/2020

Journal of General Internal Medicine 8/2020 Go to the issue